AI Article Synopsis
Article Abstract
Background: Primary bilateral macronodular adrenal hyperplasia (PBMAH), also known as adrenocorticotropic hormone (ACTH)-independent macronodular adrenal hyperplasia, is a rare cause of endogenous Cushing's syndrome. In many familial cases of PBMAH, the variants in armadillo repeat containing 5 (ARMC5) gene are found to be associated with the disease. Here, we report a case of PBMAH harboring a novel frameshift variant in ARMC5 gene, which has not been previously reported in the literature.
Case Presentation: A 67-year-old woman was referred due to the clinical features of Cushing's syndrome. Radiological imaging and hormonal testing were carried out. The serum levels of cortisol were remarkably increased at late night and did not suppress even after 1 mg of dexamethasone administration, while the plasma levels of ACTH hormone were decreased significantly. The patient underwent unilateral left-sided laparoscopic adrenalectomy, and the diagnosis of PBMAH was substantiated by histopathological analysis. Moreover, the partial envelope was incomplete and the cell proliferation index was low. Specifically, inhibin α-subunit ( +), syn focal ( +), Ki-67 ~ 3% ( +), CgA (-) and CEA (-) were observed. DNA sequencing data revealed that a novel frameshift variant (c.363_373delGCCAGTGCGCC, p.Pro122Alafs*61) was identified in ARMC5 gene. However, this variant was not detected in the daughter of the patient. The rest of the family members, including her sister, son and two brothers, were not consented for genetic testing.
Conclusions: Early detection of ARMC5 variant status and familial screening might have important clinical implications for the diagnosis and prognosis of PBMAH patients. A novel ARMC5 frameshift variant (c.363_373delGCCAGTGCGCC, p.Pro122Alafs*61) was identified to be associated with the pathogenesis of PBMAH. ARMC5 sequencing may improve the identification of a causative gene variant for PBMAH and allow earlier diagnosis of this disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396781 | PMC |
| http://dx.doi.org/10.1186/s12902-022-01128-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary bilateral macronodular adrenal hyperplasia: A rare case report of Cushing syndrome and review of literature.
Medicine (Baltimore)
October 2024
Department of Endocrinology, Vali-Asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare condition that causes Cushing syndrome (CS) and can be challenging to diagnose, making up less than 2% of CS cases.
- The case involves a 52-year-old woman experiencing multiple symptoms including fever, fatigue, and bruising, leading to an eventual diagnosis of PBMAH after lab tests and an abdominal CT scan showed increased cortisol levels and adrenal masses.
- Although the patient underwent surgery to remove one adrenal gland and her symptoms improved, she continues to rely on glucocorticoid therapy a year later, highlighting the need for more research on effective treatment options for PBMAH.
The molecular genetics of adrenal cushing.
Hormones (Athens)
December 2024
Genomic and Signaling of Endocrine Tumors team, INSERM U1016, CNRS UMR8104, Cochin Institute, Paris Cité University, Paris, 75005, France.
Article Synopsis
- - Adrenal Cushing accounts for 20% of cases of hypercorticism, with unilateral cortisol-producing adenomas (benign tumors) being more common than malignant adrenocortical carcinoma (ACC) and bilateral adrenal diseases.
- - Key signaling pathways involved in these tumors include protein kinase A and Wnt/β-catenin, with genetic predispositions identified through research on familial cases and pangenomic sequencing.
- - ACC is often linked to TP53 mutations, particularly in children, and can be associated with various hereditary syndromes, while cortisol-producing adenomas show mutations primarily in PRKACA and CTNNB1.
Long-term outcome of unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia.
Endocrine
October 2024
School of Medicine, Nankai University, Tianjin, China.
Article Synopsis
- The study investigates the long-term effectiveness of unilateral adrenalectomy (U-Adx) as a treatment for primary bilateral macronodular adrenal hyperplasia (PBMAH), a type of Cushing's syndrome, which traditionally required bilateral adrenalectomy but posed significant risks.
- Researchers evaluated 61 patients treated with U-Adx between 2004 and 2022, analyzing their postoperative biochemical outcomes and improving comorbidities such as hypertension and glucose metabolism.
- Results showed that about 50% of patients achieved initial remission within six months; however, a significant percentage experienced persistent hypercortisolism or recurrence at the last follow-up, highlighting the need for further understanding of prognostic predictors for
Aberrant hormone receptors regulate a wide spectrum of endocrine tumors.
Lancet Diabetes Endocrinol
November 2024
Univ Rouen Normandie, Inserm, NorDiC UMR 1239, Rouen, France; Department of Endocrinology, Diabetes and Metabolic Diseases, Rouen, France.
Aberrant G-protein coupled receptor (GPCR) expression is highly prevalent in cortisol-secreting primary bilateral macronodular adrenal hyperplasia (PBMAH) and unilateral adenomas. The aberrant expression of diverse GPCRs and their ligands play an important role in the over-function of various endocrine tumours. Examples include aberrant expression of MC2R, 5-HT4R, AVPR1A, LHCGR, and GnRHR in primary aldosteronism; GCGR, LHCGR, and 5-HT4R in phaeochromocytomas and paragangliomas; TRHR, GnRHR, GIPR, and GRP101 in pituitary somatotroph tumours; AVPR2, D2DR, and SSTR5 in pituitary corticotroph tumours; GLP1R, GIPR, and somatostatin receptors in medullary thyroid carcinoma; and SSTRs, GLP1R, and GIPR in other neuroendocrine tumours.
View Article and Find Full Text PDF[The value of serum dehydroepiandrosterone sulfate in the functional evaluation of adrenal space-occupying lesions in adults].
Zhonghua Nei Ke Za Zhi
September 2024
Department of Endocrinology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
To evaluate the function of serum dehydroepiandrosterone sulfate (DHEAS) in adult adrenal space-occupying lesions. In this cross-sectional study, 395 patients with adrenal space-occupying lesions who had their DHEAS levels measured were collected from the First Medical Center of Chinese PLA General Hospital from January 2010 to June 2021. They were divided into the adrenal Cushing syndrome (ACS) group (=100) and non-ACS group (=295).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!